Tiraxa® Tigecycline for Injection

【Generic Name】
Tigecycline for Injection 
【Indications】 
This product is indicated for infections caused by susceptible strains of specific bacteria in patients aged 18 years and older in the following settings: complicated intra-abdominal infection (CIAI), complicated skin and soft-tissue infection (cSSSI), and community-acquired bacterial pneumonia. 
For infections for which no other therapeutic options are available, and following consultation with an experienced infectious disease specialist or clinician, this product is indicated for the treatment of infections caused by susceptible strains of specific bacteria in pediatric patients aged 8 years and older, including: complicated intra-abdominal infections (cIAI) and complicated skin and soft-tissue infections (cSSTI). 
【Specification】 
50mg
【National Drug Approval Number H20234281】
For more information, please refer to the instruction manual.